Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women

International Journal of Cancer

Volumn 124, Issue 6, 2009, Pages 1358-1365

  Chung, Tony K H ^a   Cheung, Tak Hong ^a   Huen, Ngar Yee ^a   Wong, Katherine W Y ^a   Lo, Keith W K ^a   Yim, So Fan ^a   Siu, Nelson S S ^a   Wong, Yin Mei ^a   Tsang, Po Ting ^a   Pang, Man Wah ^a   Yu, Mei Yun ^a   To, Ka Fei ^a   Mok, Samuel C ^b   Wang, Vivian W ^b   Li, Chen ^c   Cheung, Albert Y K ^d   Doran, Graeme ^e   Birrer, Michael J ^f   Smith, David I ^g   Wong, Yick Fu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Endometrial; MicroRNA

Indexed keywords

MICRORNA; RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSFECTION; GENOME ANALYSIS; HONG KONG; HUMAN; HUMAN CELL; HUMAN TISSUE; JPH4 GENE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; CYTOLOGY; ENDOMETRIUM; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE; REFERENCE VALUE; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HONG KONG; HUMANS; MICRORNAS; MIDDLE AGED; POSTMENOPAUSE; REFERENCE VALUES; RNA, NEOPLASM;

EID: 60549101101     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24071     Document Type: Article

References (35)

1. Wong YF. Cheung TO. Lo KW, Yim SF, Siu NS, Chan SC. Ho TW. Wong KW, Yn MY, Wang VW, Li C, Gardner GJ, et al. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 2007;26:1971-827
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004:116:280-97,
3. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31.
4. Miska EA. How miRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-8.
5. Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006;22:165-73.
6. Lagos-Quitana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002:12:735-9.
7. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Alder H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13ql4 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-29.
8. Hayashita Y, Osada H, Tatemastu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawashara K. Sekido Y, Takahashi T. A poly-cistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhanced cell proliferation. Cancer Res 2006;65:9628-32.
9. Lorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri A, Musiani P, Volinia S, Nenci I, Calin GA, Querzzoli P, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005:65:7065-70.
10. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human gliobalstoma cells. Cancer Res 2005:65:6029-33.
11. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatoceilualr carcinoma and non-tumorous tissues. Oncogene 2005;25:2537-45.
12. He H, Jazddewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 2006:102:19075-80.
13. Lorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007;67:8699-707.
14. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98.
15. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Goraella LG, Croce CM, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007:25:387-92.
16. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'Brien C, Rose B. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007;358:12-17.
17. Bandrés E, Cubedo E, Agirre X, Maiumbres R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, Garciá-Foncillas J. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006;19:5-29.
18. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z, Kamath S, Chen DT, Dressman H, Lancaster JM. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol 2008;110:206-15.
19. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005;33:1290-7.
20. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 2007; 104:16170-5.
21. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 2007;120:1046-54.
22. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, Castellano L, Magrelli A, Citarella F, Messina M, Maggio R, Peragine N, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007; 109:4944-51.
23. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006;24:4677-84.
24. Schulte JH, Horn S, Otto T, Saraans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H. et al. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer 2008;122:699-704.
25. Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007;67:5699-707.
26. Garzon R, Pichiorri F, Palumbo T, Visentini M. Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, Liu CG, et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007;26:4148-57.
27. Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi FI, Yamada H, Suzuki M, Nagino M, Nimura Y, Osada H, Taka- hashi T. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 2007;26:6099-105.
28. Debernardi S, Skouiakis S, Molloy G, Chaplin T, Dixon-McTver A, Young BD. MicroRNA miR- 181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007;21:912-16.
29. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 2007;67:976-83.
30. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva WA Jr. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 2007;40:1435-40.
31. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Torio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-61.
32. Barbarotto E, Schmittgen TD, Calin GA. MicroRNAs and cancer: profile, profile, profile. Int J Cancer 2007;122:969-77.
33. Gregaory PA. Bert AG. Paterson EL. Barry SC, Tsykin A. Farshid G. Vadas MA, Goodal YK, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP 1. Nature Cell Biol 2008;10:593-601.
34. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB 1 and ZEB2. Genes Dev 2008;22:894-907.
35. Miska EA. MicroRNAs-keeping cells in formation. Nature Cell Biol 2008;10:501-2.